BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 20347657)

  • 1. Onychomycosis.
    Welsh O; Vera-Cabrera L; Welsh E
    Clin Dermatol; 2010 Mar; 28(2):151-9. PubMed ID: 20347657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An open randomized comparative study to test the efficacy and safety of oral terbinafine pulse as a monotherapy and in combination with topical ciclopirox olamine 8% or topical amorolfine hydrochloride 5% in the treatment of onychomycosis.
    Jaiswal A; Sharma RP; Garg AP
    Indian J Dermatol Venereol Leprol; 2007; 73(6):393-6. PubMed ID: 18032857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.
    Gupta AK
    J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S81-95. PubMed ID: 11051137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Itraconazole and terbinafine treatment of some nondermatophyte molds causing onychomycosis of the toes and a review of the literature.
    Gupta AK; Gregurek-Novak T; Konnikov N; Lynde CW; Hofstader S; Summerbell RC
    J Cutan Med Surg; 2001; 5(3):206-10. PubMed ID: 11685666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifungal Drugs for Onychomycosis: Efficacy, Safety, and Mechanisms of Action.
    Rosen T; Stein Gold LF
    Semin Cutan Med Surg; 2016 Mar; 35(3 Suppl 3):S51-5. PubMed ID: 27074700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapies for the treatment of onychomycosis.
    Gupta AK; Paquet M; Simpson FC
    Clin Dermatol; 2013; 31(5):544-54. PubMed ID: 24079583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Onychomycosis: Diagnosis and management.
    Singal A; Khanna D
    Indian J Dermatol Venereol Leprol; 2011; 77(6):659-72. PubMed ID: 22016272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.
    Gupta AK; Gregurek-Novak T
    Dermatology; 2001; 202(3):235-8. PubMed ID: 11385230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sporicidal effect of amorolfine and other antimycotics used in the therapy of fungal nail infections.
    Seidl HP; Jäckel A; Müller J; Schaller M; Borelli C; Polak A
    Mycoses; 2015 Oct; 58(10):610-9. PubMed ID: 26334024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toenail onychomycosis: current and future treatment options.
    Finch JJ; Warshaw EM
    Dermatol Ther; 2007; 20(1):31-46. PubMed ID: 17403258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Onychomycosis insensitive to systemic terbinafine and azole treatments reveals non-dermatophyte moulds as infectious agents.
    Baudraz-Rosselet F; Ruffieux C; Lurati M; Bontems O; Monod M
    Dermatology; 2010; 220(2):164-8. PubMed ID: 20110639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of dermatophyte toenail onychomycosis in the United States. A pharmacoeconomic analysis.
    Gupta AK
    J Am Podiatr Med Assoc; 2002 May; 92(5):272-86. PubMed ID: 12015408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Terbinafine: a review of its use in onychomycosis in adults.
    Darkes MJ; Scott LJ; Goa KL
    Am J Clin Dermatol; 2003; 4(1):39-65. PubMed ID: 12477372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Onychomycosis: pathogenesis, diagnosis, and management.
    Elewski BE
    Clin Microbiol Rev; 1998 Jul; 11(3):415-29. PubMed ID: 9665975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Open randomized comparison of itraconazole versus terbinafine in onychomycosis.
    Arenas R; Domínguez-Cherit J; Fernández LM
    Int J Dermatol; 1995 Feb; 34(2):138-43. PubMed ID: 7737776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Onychomycosis: recent progress in the epidemiology, diagnosis and treatment].
    Hiruma M
    Nihon Ishinkin Gakkai Zasshi; 2006; 47(2):69-73. PubMed ID: 16699485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral treatment options for onychomycosis.
    Joseph WS
    J Am Podiatr Med Assoc; 1997 Nov; 87(11):520-31. PubMed ID: 9397657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Onychomycosis in children: a brief overview with treatment strategies.
    Gupta AK; Skinner AR
    Pediatr Dermatol; 2004; 21(1):74-9. PubMed ID: 14871333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial of amorolfine 5% solution nail lacquer in association with itraconazole pulse therapy compared with itraconazole alone in the treatment of Candida fingernail onychomycosis.
    Rigopoulos D; Katoulis AC; Ioannides D; Georgala S; Kalogeromitros D; Bolbasis I; Karistinou A; Christofidou E; Polydorou D; Balkou P; Fragouli E; Katsambas AD
    Br J Dermatol; 2003 Jul; 149(1):151-6. PubMed ID: 12890209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic evaluation of antifungal agents in the treatment of toenail onychomycosis in Germany.
    Van Doorslaer EK; Tormans G; Gupta AK; Van Rossem K; Eggleston A; Dubois DJ; De Doncker P; Haneke E
    Dermatology; 1996; 193(3):239-44. PubMed ID: 8944348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.